• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膜联蛋白II/p11相互作用的破坏抑制白血病细胞的黏附、归巢和植入,并使白血病细胞对化疗敏感。

Disruption of Annexin II /p11 Interaction Suppresses Leukemia Cell Binding, Homing and Engraftment, and Sensitizes the Leukemia Cells to Chemotherapy.

作者信息

Gopalakrishnapillai Anilkumar, Kolb E Anders, Dhanan Priyanka, Mason Robert W, Napper Andrew, Barwe Sonali P

机构信息

Nemours Center for Childhood Cancer Research, Alfred I. duPont Hospital for Children, Wilmington, DE, 19803, United States of America.

出版信息

PLoS One. 2015 Oct 14;10(10):e0140564. doi: 10.1371/journal.pone.0140564. eCollection 2015.

DOI:10.1371/journal.pone.0140564
PMID:26465153
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4605480/
Abstract

The bone marrow microenvironment plays an important role in acute lymphoblastic leukemia (ALL) cell proliferation, maintenance, and resistance to chemotherapy. Annexin II (ANX2) is abundantly expressed on bone marrow cells and complexes with p11 to form ANX2/p11-hetero-tetramer (ANX2T). We present evidence that p11 is upregulated in refractory ALL cell lines and patient samples. A small molecule inhibitor that disrupts ANX2/p11 interaction (ANX2T inhibitor), an anti-ANX2 antibody, and knockdown of p11, abrogated ALL cell adhesion to osteoblasts, indicating that ANX2/p11 interaction facilitates binding and retention of ALL cells in the bone marrow. Furthermore, ANX2T inhibitor increased the sensitivity of primary ALL cells co-cultured with osteoblasts to dexamethasone and vincristine induced cell death. Finally, in an orthotopic leukemia xenograft mouse model, the number of ALL cells homing to the bone marrow was reduced by 40-50% in mice injected with anti-ANX2 antibody, anti-p11 antibody or ANX2T inhibitor compared to respective controls. In a long-term engraftment assay, the percentage of ALL cells in mouse blood, bone marrow and spleen was reduced in mice treated with agents that disrupt ANX2/p11 interaction. These data show that disruption of ANX2/p11 interaction results in reduced ALL cell adhesion to osteoblasts, increased ALL cell sensitization to chemotherapy, and suppression of ALL cell homing and engraftment.

摘要

骨髓微环境在急性淋巴细胞白血病(ALL)细胞增殖、维持及化疗耐药中发挥重要作用。膜联蛋白II(ANX2)在骨髓细胞上大量表达,并与p11形成复合物,构成ANX2/p11异源四聚体(ANX2T)。我们提供的证据表明,p11在难治性ALL细胞系和患者样本中上调。一种破坏ANX2/p11相互作用的小分子抑制剂(ANX2T抑制剂)、抗ANX2抗体以及p11基因敲低,均消除了ALL细胞与成骨细胞的黏附,表明ANX2/p11相互作用促进ALL细胞在骨髓中的结合与滞留。此外,ANX2T抑制剂增加了与成骨细胞共培养的原代ALL细胞对地塞米松和长春新碱诱导的细胞死亡的敏感性。最后,在原位白血病异种移植小鼠模型中,与各自对照组相比,注射抗ANX2抗体、抗p11抗体或ANX2T抑制剂的小鼠归巢至骨髓的ALL细胞数量减少了40 - 50%。在长期植入试验中,用破坏ANX2/p11相互作用的药物处理的小鼠,其血液、骨髓和脾脏中ALL细胞的百分比降低。这些数据表明,破坏ANX2/p11相互作用会导致ALL细胞与成骨细胞的黏附减少、ALL细胞对化疗的敏感性增加以及ALL细胞归巢和植入受到抑制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e473/4605480/31d36c1aef31/pone.0140564.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e473/4605480/b4f1b042d013/pone.0140564.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e473/4605480/f5fe14e4ad43/pone.0140564.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e473/4605480/a2313f4634ad/pone.0140564.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e473/4605480/e9a491b9fdc5/pone.0140564.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e473/4605480/eee86e4f8cdc/pone.0140564.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e473/4605480/31d36c1aef31/pone.0140564.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e473/4605480/b4f1b042d013/pone.0140564.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e473/4605480/f5fe14e4ad43/pone.0140564.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e473/4605480/a2313f4634ad/pone.0140564.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e473/4605480/e9a491b9fdc5/pone.0140564.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e473/4605480/eee86e4f8cdc/pone.0140564.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e473/4605480/31d36c1aef31/pone.0140564.g006.jpg

相似文献

1
Disruption of Annexin II /p11 Interaction Suppresses Leukemia Cell Binding, Homing and Engraftment, and Sensitizes the Leukemia Cells to Chemotherapy.膜联蛋白II/p11相互作用的破坏抑制白血病细胞的黏附、归巢和植入,并使白血病细胞对化疗敏感。
PLoS One. 2015 Oct 14;10(10):e0140564. doi: 10.1371/journal.pone.0140564. eCollection 2015.
2
BCL6 modulation of acute lymphoblastic leukemia response to chemotherapy.BCL6对急性淋巴细胞白血病化疗反应的调节作用。
Oncotarget. 2016 Apr 26;7(17):23439-53. doi: 10.18632/oncotarget.8273.
3
Src kinase-induced phosphorylation of annexin A2 mediates glucocorticoid resistance in MLL-rearranged infant acute lymphoblastic leukemia.Src 激酶诱导的膜联蛋白 A2 磷酸化介导 MLL 重排婴儿急性淋巴细胞白血病对糖皮质激素的耐药性。
Leukemia. 2013 Apr;27(5):1063-71. doi: 10.1038/leu.2012.372. Epub 2012 Dec 28.
4
The central nervous system microenvironment influences the leukemia transcriptome and enhances leukemia chemo-resistance.中枢神经系统微环境影响白血病转录组并增强白血病化疗耐药性。
Haematologica. 2017 Apr;102(4):e136-e139. doi: 10.3324/haematol.2016.152926. Epub 2016 Dec 29.
5
Endothelial cell annexin A2 regulates polyubiquitination and degradation of its binding partner S100A10/p11.内皮细胞膜联蛋白A2调节其结合伴侣S100A10/p11的多聚泛素化和降解。
J Biol Chem. 2008 Jul 11;283(28):19192-200. doi: 10.1074/jbc.M800100200. Epub 2008 Apr 23.
6
Targeting bone marrow lymphoid niches in acute lymphoblastic leukemia.靶向急性淋巴细胞白血病中的骨髓淋巴微环境。
Leuk Res. 2015 Dec;39(12):1437-42. doi: 10.1016/j.leukres.2015.09.020. Epub 2015 Oct 1.
7
Shp2 activation in bone marrow microenvironment mediates the drug resistance of B-cell acute lymphoblastic leukemia through enhancing the role of VCAM-1/VLA-4.骨髓微环境中 Shp2 的激活通过增强 VCAM-1/VLA-4 的作用介导 B 细胞急性淋巴细胞白血病的耐药性。
Int Immunopharmacol. 2020 Mar;80:106008. doi: 10.1016/j.intimp.2019.106008. Epub 2020 Jan 21.
8
Preclinical activity of LBH589 alone or in combination with chemotherapy in a xenogeneic mouse model of human acute lymphoblastic leukemia.LBH589 单药或联合化疗在人急性淋巴细胞白血病异种移植模型中的临床前活性。
Leukemia. 2012 Jul;26(7):1517-26. doi: 10.1038/leu.2012.31. Epub 2012 Feb 6.
9
Up-regulated A20 promotes proliferation, regulates cell cycle progression and induces chemotherapy resistance of acute lymphoblastic leukemia cells.上调的A20促进急性淋巴细胞白血病细胞的增殖,调节细胞周期进程并诱导化疗耐药。
Leuk Res. 2015 Sep;39(9):976-83. doi: 10.1016/j.leukres.2015.06.004. Epub 2015 Jun 10.
10
BACH2-mediated FOS confers cytarabine resistance via stromal microenvironment alterations in pediatric ALL.BACH2 介导的 FOS 通过改变小儿 ALL 中的基质微环境赋予阿糖胞苷耐药性。
Cancer Sci. 2021 Mar;112(3):1235-1250. doi: 10.1111/cas.14792. Epub 2021 Jan 22.

引用本文的文献

1
Characteristics, risk factors and a risk prediction model of tocilizumab-induced hypofibrinogenemia: a retrospective real-world study of inpatients.托珠单抗诱导的低纤维蛋白原血症的特征、危险因素及风险预测模型:一项住院患者的回顾性真实世界研究
BMC Pharmacol Toxicol. 2025 Jan 9;26(1):5. doi: 10.1186/s40360-024-00827-6.
2
Characterizations of annexin A1-interacting proteins in apical membrane and cytosolic compartments of renal tubular epithelial cells.肾小管上皮细胞顶端膜和胞质区室中膜联蛋白A1相互作用蛋白的表征。
Comput Struct Biotechnol J. 2023 Jul 29;21:3796-3809. doi: 10.1016/j.csbj.2023.07.037. eCollection 2023.
3

本文引用的文献

1
Osteoblasts protect AML cells from SDF-1-induced apoptosis.成骨细胞可保护急性髓系白血病细胞免受基质细胞衍生因子-1诱导的凋亡。
J Cell Biochem. 2014 Jun;115(6):1128-37. doi: 10.1002/jcb.24755.
2
Protein interactions between surface annexin A2 and S100A10 mediate adhesion of breast cancer cells to microvascular endothelial cells.表面膜联蛋白 A2 和 S100A10 之间的蛋白相互作用介导乳腺癌细胞黏附于微血管内皮细胞。
FEBS Lett. 2013 Oct 1;587(19):3210-5. doi: 10.1016/j.febslet.2013.08.012. Epub 2013 Aug 27.
3
Src kinase-induced phosphorylation of annexin A2 mediates glucocorticoid resistance in MLL-rearranged infant acute lymphoblastic leukemia.
Açaí ( Mart.) Seed Oil Exerts a Cytotoxic Role over Colorectal Cancer Cells: Insights of Annexin A2 Regulation and Molecular Modeling.
阿萨伊(Mart.)籽油对结肠癌细胞发挥细胞毒性作用:膜联蛋白A2调控及分子建模的见解
Metabolites. 2023 Jun 25;13(7):789. doi: 10.3390/metabo13070789.
4
Bone Marrow Microenvironment-Induced Chemoprotection in Rearranged Pediatric AML Is Overcome by Azacitidine-Panobinostat Combination.阿扎胞苷-帕比司他联合用药克服了骨髓微环境诱导的小儿急性髓系白血病重排中的化学保护作用。
Cancers (Basel). 2023 Jun 8;15(12):3112. doi: 10.3390/cancers15123112.
5
The Bone Marrow Microenvironment in B-Cell Development and Malignancy.B细胞发育与恶性肿瘤中的骨髓微环境
Cancers (Basel). 2022 Apr 22;14(9):2089. doi: 10.3390/cancers14092089.
6
In Positive B-Cell Acute Lymphoblastic Leukemia, Steroid Therapy Induces Hypofibrinogenemia.在阳性B细胞急性淋巴细胞白血病中,类固醇疗法会诱发低纤维蛋白原血症。
J Clin Med. 2022 Mar 23;11(7):1776. doi: 10.3390/jcm11071776.
7
Clinical significance of serum S100A10 in lung cancer.血清 S100A10 在肺癌中的临床意义。
J Int Med Res. 2021 Oct;49(10):3000605211049653. doi: 10.1177/03000605211049653.
8
Plasmin and Plasminogen System in the Tumor Microenvironment: Implications for Cancer Diagnosis, Prognosis, and Therapy.肿瘤微环境中的纤溶酶和纤溶酶原系统:对癌症诊断、预后及治疗的意义
Cancers (Basel). 2021 Apr 12;13(8):1838. doi: 10.3390/cancers13081838.
9
Annexin Animal Models-From Fundamental Principles to Translational Research. annexin 动物模型——从基础原理到转化研究。
Int J Mol Sci. 2021 Mar 26;22(7):3439. doi: 10.3390/ijms22073439.
10
S100A10 Accelerates Aerobic Glycolysis and Malignant Growth by Activating mTOR-Signaling Pathway in Gastric Cancer.S100A10通过激活胃癌中的mTOR信号通路加速有氧糖酵解和恶性生长。
Front Cell Dev Biol. 2020 Nov 26;8:559486. doi: 10.3389/fcell.2020.559486. eCollection 2020.
Src 激酶诱导的膜联蛋白 A2 磷酸化介导 MLL 重排婴儿急性淋巴细胞白血病对糖皮质激素的耐药性。
Leukemia. 2013 Apr;27(5):1063-71. doi: 10.1038/leu.2012.372. Epub 2012 Dec 28.
4
Annexin II interactions with the annexin II receptor enhance multiple myeloma cell adhesion and growth in the bone marrow microenvironment.膜联蛋白 II 与膜联蛋白 II 受体的相互作用增强多发性骨髓瘤细胞在骨髓微环境中的黏附和生长。
Blood. 2012 Feb 23;119(8):1888-96. doi: 10.1182/blood-2011-11-393348. Epub 2012 Jan 5.
5
Design, synthesis, and structure-activity relationship exploration of 1-substituted 4-aroyl-3-hydroxy-5-phenyl-1H-pyrrol-2(5H)-one analogues as inhibitors of the annexin A2-S100A10 protein interaction.设计、合成及 1-取代 4-芳酰基-3-羟基-5-苯基-1H-吡咯-2(5H)-酮类似物的结构活性关系研究,作为膜联蛋白 A2-S100A10 蛋白相互作用抑制剂。
J Med Chem. 2011 Apr 14;54(7):2080-94. doi: 10.1021/jm101212e. Epub 2011 Mar 4.
6
Gene expression signatures predictive of early response and outcome in high-risk childhood acute lymphoblastic leukemia: A Children's Oncology Group Study [corrected].预测高危儿童急性淋巴细胞白血病早期反应和预后的基因表达特征:一项儿童肿瘤学组研究[校正后]
J Clin Oncol. 2008 Sep 20;26(27):4376-84. doi: 10.1200/JCO.2007.14.4519.
7
Investigation of chromosome 1q reveals differential expression of members of the S100 family in clinical subgroups of intracranial paediatric ependymoma.对1号染色体q臂的研究揭示了S100家族成员在儿童颅内室管膜瘤临床亚组中的差异表达。
Br J Cancer. 2008 Oct 7;99(7):1136-43. doi: 10.1038/sj.bjc.6604651. Epub 2008 Sep 9.
8
Novel molecular and cellular therapeutic targets in acute lymphoblastic leukemia and lymphoproliferative disease.急性淋巴细胞白血病和淋巴增殖性疾病中的新型分子与细胞治疗靶点。
Immunol Res. 2008;42(1-3):84-105. doi: 10.1007/s12026-008-8038-9.
9
Annexin II/annexin II receptor axis regulates adhesion, migration, homing, and growth of prostate cancer.膜联蛋白II/膜联蛋白II受体轴调节前列腺癌的黏附、迁移、归巢和生长。
J Cell Biochem. 2008 Oct 1;105(2):370-80. doi: 10.1002/jcb.21835.
10
Endothelial cell annexin A2 regulates polyubiquitination and degradation of its binding partner S100A10/p11.内皮细胞膜联蛋白A2调节其结合伴侣S100A10/p11的多聚泛素化和降解。
J Biol Chem. 2008 Jul 11;283(28):19192-200. doi: 10.1074/jbc.M800100200. Epub 2008 Apr 23.